Downloads: 2
India | Medical Science | Volume 14 Issue 10, October 2025 | Pages: 1080 - 1083
Fluoroscopy Guided Intra-Articular Corticosteroid Infiltration for Sacroiliac Joint Arthropathy
Abstract: Introduction: Sacroiliitis represents the hallmark of spondylarthritis and manifests as gluteal pain associated with morning stiffness (MS). Non-steroidal anti-inflammatory drugs (NSAIDs) and disease modifying drugs (DMARDs) not only mandate longer duration of treatment but also proves unsatisfactory in achieving a remission. Literature on clinical outcome of sacroiliac joint injection (SIJI) with methylprednisolone is less available. Materials and methods: We enrolled patients presented with pain due to sacroiliitis confirmed via magnetic resonance imaging (MRI) and managed with intra-articular injection of methylprednisolone, hyaluronidase, and bupivacaine at sacroiliac joint (SIJ) under fluoroscopy guidance. Pre-and-post intervention numerical rating pain score (NRPS) and Oswestry disability Index (ODI) was recorded and analyzed. Results: We enrolled 31 patients, mean age 55???22 years; 20 females and 11 males;?mean duration of sacroiliitis 36.82???12 months; 94% patients were on NSAIDs; 6% on NSAIDs and DMARDs; over all 52 SIJ injected; Preoperative mean NRS and ODI was 6.5+/-1.2 and 70.6+/-10.2 respectively. Postoperative median NRS and ODI on day 7, month 1 and month 3 were 3.5, 3.1 and 2.2; and 20.6, 18.1 and 18.5 respectively. Statistically significant drop in NRS and ODI observed (p?
Keywords: Sacroiliitis, Numerical Rating Pain Score, Oswestry Disability Index, Fluoroscopy, Sacroiliac joint injections
How to Cite?: Pankaj N Surange, Arunkumar Muthu Subramanian, Harshita Surange, Swati Bhat, Gopi Chellan, "Fluoroscopy Guided Intra-Articular Corticosteroid Infiltration for Sacroiliac Joint Arthropathy", Volume 14 Issue 10, October 2025, International Journal of Science and Research (IJSR), Pages: 1080-1083, https://www.ijsr.net/getabstract.php?paperid=SR251020172024, DOI: https://dx.doi.org/10.21275/SR251020172024